⚡ Asset Showdown Engine

LLY vs NVO

Head-to-head financial comparison for Eli Lilly and Co (LLY) and Novo Nordisk A/S (NVO).

🏆 Showdown Verdict

NVO leads LLY in 9 of 17 key financial metrics.

LLY: 8 wins · NVO: 9 wins
NEW YORK STOCK EXCHANGE, INC. · Pharmaceuticals

LLY

Eli Lilly and Co
$1,152.12
-0.66%
Market open
52-Week Range 75.8% of High
Low: $712.05 High: $1,292.65
💼
Profitability Winner Higher Operating & Net Margins
🚀
Performance Winner Higher Historical Returns
OMX NORDIC EXCHANGE COPENHAGEN A/S · Pharmaceuticals

NVO

Novo Nordisk A/S
$1,152.12
-0.66%
Market open
52-Week Range 75.8% of High
Low: $712.05 High: $1,292.65
💼
Profitability Winner Higher Operating & Net Margins
🚀
Performance Winner Higher Historical Returns
OMX NORDIC EXCHANGE COPENHAGEN A/S · Pharmaceuticals

NVO

Novo Nordisk A/S
$47.26
+1.08%
Market open
52-Week Range 41.8% of High
Low: $35.12 High: $64.16
🏷️
Valuation Winner Lower P/E & Multiples
💰
Income Winner Higher Dividend Yield
🏛️
Scale Leader Larger Market Cap

Normalized % Return Comparison

Both assets indexed to 0.0% at the period start: ((Price_t - Price_0) / Price_0 * 100)

LLY (Eli Lilly and Co) +58.17%
NVO (Novo Nordisk A/S) -13.48%
LLY leads by +71.65%
-53.0%-16.6%+19.9%+56.3%+92.8% Aug '25Nov '25Mar '26Jun '26Sep '26

Metric-by-Metric Breakdown

Direct quantitative comparison across valuation, margins, growth, and returns.

Financial Metric LLY NVO Showdown Advantage
Valuation & Multiples
Price Current market price per share / unit $1,152.12 $47.26
Market Capitalization Total aggregate market value of equity $1.09T $1.30T 👑 NVO Larger
P/E Ratio (Trailing TTM) Price-to-earnings multiple (lower positive is cheaper) 43.17x 11.40x 👑 NVO Cheaper
Forward P/E Price-to-projected next year earnings multiple 28.48x 14.36x 👑 NVO Lower
PEG Ratio P/E divided by earnings growth rate (<1.0 considered undervalued) 1.48 16.16 👑 LLY Lower
Price to Sales (P/S) Price relative to trailing revenue 14.47x 4.03x 👑 NVO Lower
Price to Book (P/B) Stock price relative to book equity per share 33.34x 4.82x 👑 NVO Lower
Profitability & Margins
Gross Profit Margin Gross revenue retained after cost of goods sold 83.40% 80.65% 👑 LLY Higher
Operating Margin Operating income generated per dollar of revenue 42.22% 43.13% 👑 NVO Higher
Net Profit Margin Net bottom-line profit generated per dollar of revenue 33.53% 35.35% 👑 NVO Higher
Return on Equity (ROE) Net income earned per dollar of shareholders' equity 92.58% 59.09% 👑 LLY Higher
Historical Performance & Growth
Revenue Growth (YoY) Year-over-year top-line revenue expansion rate +47.67% +2.12% 👑 LLY Higher
1-Month % Return Historical total price return over the past 30 days -0.27% -7.59% 👑 LLY Higher
6-Month % Return Historical total price return over the past 180 days +14.53% +3.03% 👑 LLY Higher
1-Year % Return Historical total price return over the past 52 weeks +58.17% -13.48% 👑 LLY Higher
5-Year % Return Historical total price return over 5 years +364.03% +2948.39% 👑 NVO Higher
Dividends & Risk
Dividend Yield Annual dividend distributions relative to current price 0.75% 1.00% 👑 NVO Higher
Beta (Volatility vs S&P 500) Market sensitivity (1.0 = equal to market, <1.0 = lower volatility) 0.43 1.93
52-Week High & Low Extreme trading boundaries over trailing year $712.05 – $1,292.65 $35.12 – $64.16